<SEC-DOCUMENT>0001564590-19-009342-index.html : 20190326
<SEC-HEADER>0001564590-19-009342.hdr.sgml : 20190326
<ACCEPTANCE-DATETIME>20190326161042
ACCESSION NUMBER:		0001564590-19-009342
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20190326
DATE AS OF CHANGE:		20190326
EFFECTIVENESS DATE:		20190326

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PhaseBio Pharmaceuticals Inc
		CENTRAL INDEX KEY:			0001169245
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				030375697
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-230504
		FILM NUMBER:		19705407

	BUSINESS ADDRESS:	
		STREET 1:		1 GREAT VALLEY PARKWAY
		STREET 2:		SUITE 30
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355
		BUSINESS PHONE:		(610) 981-6500

	MAIL ADDRESS:	
		STREET 1:		1 GREAT VALLEY PARKWAY
		STREET 2:		SUITE 30
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Phase Biosciences Inc
		DATE OF NAME CHANGE:	20061013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DT BIOSCIENCES INC
		DATE OF NAME CHANGE:	20020315
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>phas-s8.htm
<DESCRIPTION>S-8
<TEXT>
Document 1 - file: phas-s8.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>phas-ex51_7.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 2 - file: phas-ex51_7.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>phas-ex231_6.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 3 - file: phas-ex231_6.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>gfmydxp1nmuw000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: gfmydxp1nmuw000001.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>gfmydxp1nmuw000002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: gfmydxp1nmuw000002.jpg

</DOCUMENT>
</SEC-DOCUMENT>